CID is 3899
synonyms found at PubChem are:
leflunomide, 75706-12-6, Arava, Leflunomidum, lefunamide, Leflunomida, HWA 486, Leflunomidum [INN-Latin], HWA-486, 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide, Leflunomida [INN-Spanish], SU 101 (pharmaceutical), Arava (TN), Leflunomid, Repso, Lefunomide [Inn-Spanish], Leflunomide [USAN:INN], SU101, 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide, UNII-G162GK9U4W, SU-101, 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide, 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-, alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide, HSDB 7289, CHEMBL960, RS-34821, Leflunomide (JAN/USAN/INN), MLS000069648, CHEBI:6402, G162GK9U4W, N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide, 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide), SU 101, N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide, NCGC00015610-02, SMR000058209, 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide, 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-, CAS-75706-12-6, DSSTox_CID_3201, L 5025, DSSTox_RID_76923, DSSTox_GSID_23201, 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide, 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl, 4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl), leflunomide medac, SR-01000000191, avara, lefumide, Lefunomide, Arabloc, Prestwick_87, Arava, Leflunomide, Leflunomide [USAN:USP:INN:BAN], SULOL, Spectrum_000322, AC1L1GYK, AC1Q2EVA, Opera_ID_1709, Prestwick0_000772, Prestwick1_000772, Prestwick2_000772, Prestwick3_000772, Spectrum5_000850, Lopac-L-5025, D08ROP, SCHEMBL5057, Aventis Brand of Leflunomide, Hoechst Brand of Leflunomide, BIDD:PXR0189, Lopac0_000649, BSPBio_000844, KBioSS_000802, Leflunomide, Immunosuppressant, MLS001076267, DivK1c_000916, SPECTRUM1503927, SPBio_002783, BPBio1_000930, GTPL6825, ISO054, ZINC4840, DTXSID9023201, CTK8G0535, HMS502N18, KBio1_000916, KBio2_000802, KBio2_003370, KBio2_005938, KS-00000KQI, AOB5964, MolPort-002-345-613, NINDS_000916, VHOGYURTWQBHIL-UHFFFAOYSA-N, 5-methyl-n-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamid, HMS1570K06, HMS1922M06, HMS2090O12, HMS2097K06, HMS2235C07, HMS3262A19, HMS3268D12, HMS3371F21, HMS3654F07, HMS3714K06, Pharmakon1600-01503927, ALBB-019233, Aventis Pharma Brand of Leflunomide, BCP22241, EBD46417, HY-B0083, Tox21_110182, Tox21_301873, Tox21_500649, ABP001076, Aventis Behring Brand of Leflunomide, BDBM50054601, DL-433, MFCD00867593, NSC677411, NSC759864, s1247, STL426823, AKOS000265193, Tox21_110182_1, AC-6796, AN-9632, BCP9000846, CCG-204736, CS-1781, DB01097, KS-1076, LP00649, MCULE-9490869974, NSC-677411, NSC-759864, RP29613, IDI1_000916, NCGC00015610-01, NCGC00015610-03, NCGC00015610-04, NCGC00015610-05, NCGC00015610-06, NCGC00015610-07, NCGC00015610-08, NCGC00015610-09, NCGC00015610-10, NCGC00015610-11, NCGC00015610-12, NCGC00015610-13, NCGC00015610-14, NCGC00015610-17, NCGC00015610-18, NCGC00022625-03, NCGC00022625-04, NCGC00022625-05, NCGC00022625-06, NCGC00022625-07, NCGC00022625-08, NCGC00255370-01, NCGC00261334-01, AJ-08231, BC204155, H527, LS-86580, SC-46541, ST079287, ZB000596, AB0007396, TL8005179, A9622, AB00052389, EU-0100649, FT-0621959, L0250, R3926, ST24047486, C07905, D00749, MLS-0003109.0001, AB00052389-17, AB00052389-18, AB00052389_19, AB00052389_21, 706L126, AP-501/42475599, A77 1486, I06-2131, Q-201289, SR-01000000191-2, SR-01000000191-4, SR-01000000191-7, BRD-K78692225-001-03-9, BRD-K78692225-001-11-2, 5-methyl-4-(4-trifluoromethyl-phenyl)aminocarbonylisoxazole, 5-methyl-4-(4-trifluoromethylphenyl)aminocarbonylisoxazole, 5-METHYLISOXAZOLE-4-(4-TRIFLUOROMETHYLCARBOXANILID, Leflunomide, European Pharmacopoeia (EP) Reference Standard, N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide;, 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)-anilide, N-(4-trifluoromethylphenyl)-5-methylisoxa-zole-4-carboxamide, (5-methylisoxazol-4-yl)-N-[4-(trifluoromethyl)phenyl]carboxamide, Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-, Leflunomide, United States Pharmacopeia (USP) Reference Standard, Leflunomide, Pharmaceutical Secondary Standard; Certified Reference Material, Leflunomide for peak identification, European Pharmacopoeia (EP) Reference Standard, 210165-51-8